How to Adjust Economic Models for Health Equity in the Conduct of Generalized Cost-Effectiveness Analysis (GCEA)

Speaker(s)

Darius Lakdawalla, PhD, School of Pharmacy, USC Leonard D. Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA, Anirban Basu, PhD, MS, The CHOICE Institute, University of Washington, Seattle, WA, USA, Vasco M Pontinha, PhD, MPharm, MBA, Virginia Commonwealth University School of Pharmacy, Richmond, VA, USA, William Vincent Padula, PhD, MSc, MS, Pharmaceutical & Health Economics, University of Southern California, Los Angeles, CA, USA and Nancy Joy Devlin, PhD, School of Population and Global Health, University of Melbourne, Melbourne, Australia

The ISPOR value flower has provided the field with a list of ‘what’ novel value elements should be incorporated into cost-effectiveness analysis (CEA), among them the value of health equity. Health equity, while important to consider, does not have an established system of measurement and weighting on economic evaluation. Recent measurement and methodological advancements that consider the importance of health equity on decision-making can play into approaches for generalized cost-effectiveness analysis (GCEA).

Padula will provide an overview GCEA and the relative importance of adjusting economic models for health equity. Lakdawalla will introduce the generalized risk-adjusted cost-effectiveness (GRACE) framework as a way of overcoming discriminatory decision-making by adjusting for baseline disability and concerns about health equity. Basu will introduce a new measurement system to health utility, Healthy Years in Total (HYT) as an alternative to QALYs that addressed health equity concerns. Vasco Pontinha will introduce a novel method to encapsulate health equity based on budgetary constraints for mainstream health technologies. At the end of the workshop, the discussants will poll the audience about which method(s) may be able to gain traction to make U.S. health technology assessment processes more equitable.

Code

319

Topic

Economic Evaluation